20
Participants
Start Date
June 1, 1996
Primary Completion Date
September 7, 1999
Study Completion Date
September 7, 1999
Group A
one nebulization with 250mg alpha-1-antitrypsine diluted in 10ml injectable solution once a day during 1 month. A CR-60 high flow compressor and Ventstream nebulizer were used for nebulization.
Group B
10ml of 0.9% NaCl saline solution nebulised once daily for 1 month. A CR-60 high flow compressor and Ventstream nebulizer were used for nebulization.
Collaborators (1)
Bayer
INDUSTRY
Sociedad Española de Neumología y Cirugía Torácica
OTHER
Instituto de Salud Carlos III
OTHER_GOV
Hospital Universitari Vall d'Hebron Research Institute
OTHER